Study of Quality of Life After Surgery for Stage I-IV Rectal Cancer

What this Trial Is About

Researchers are evaluating quality of life and health state utilities in patients with stage I-IV rectal cancer who have undergone surgical treatment. The study aims to understand how treatment affects patients well-being over time and to compare the impact of treatments with or without neoadjuvant radiation therapy. This observational study may help improve knowledge about living with or after rectal cancer. Participants complete quality of life questionnaires at several time points before surgery, at 6 and 12 months after surgery, and then annually at 2, 3, 4, and 5 years post-surgery. These repeated assessments help capture changes in quality of life and health status over an extended period. The study is sponsored by M.D. Anderson Cancer Center and involves no interventional treatments. During the study, participants will spend about 20 to 30 minutes completing questionnaires at each visit. Researchers analyze these responses to measure health state utilities and quality of life changes over time, focusing especially on data collected at 24 months after surgery. This long-term follow-up provides valuable insight into patient experiences after rectal cancer surgery, with the overall participation lasting up to five years.

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer